✦ LIBER ✦

Interferon-alpha-2b enhances the natural killer activity of patients with transitional cell carcinoma of the bladder

✍ Scribed by Joaquín A. Carballido; Luis M. Moltó; Luis Manzano; Carlos Olivier; Octavio J. Salmerón; Melchor Alvarez de Mon

Publisher: John Wiley and Sons
Year: 1993
Tongue: English
Weight: 574 KB
Volume: 72
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19930901)72:5<1743::aid-cncr2820720538>3.0.co;2-t

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Interferon β enhances the natural killer

Interferon β enhances the natural killer activity of patients with bladder carcinoma

✍ Luis Moltó; Joaquin Carballido; Luis Manzano; Carlos Olivier; Pilar Lapeña; Melc 📂 Article 📅 1994 🏛 Springer-Verlag 🌐 English ⚖ 546 KB

Thymostimulin enhances the natural cytot

Thymostimulin enhances the natural cytotoxic activity of patients with transitional cell carcinoma of the bladder

✍ Luis M. Moltó; Joaquin A. Carballido; Luis Manzano; Carlos Olivier; Maria Lapuer 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 514 KB

Modulation by interferon alpha of the de

Modulation by interferon alpha of the decreased natural killer activity in patients with glioblastoma

✍ P. Lapeña; C. Isasi; J. Vaquero; R. Martinez; M. Alvarez-Mon 📂 Article 📅 1991 🏛 Springer Vienna 🌐 English ⚖ 467 KB

Treatment of patients with transitional

Treatment of patients with transitional cell carcinoma of the urinary bladder with intravesical poly I: Poly C effects on natural killer function

✍ C. Moroz; B. Kupfer; A. Lindner; M. Many 📂 Article 📅 1985 🏛 Springer-Verlag 🌐 English ⚖ 456 KB

Evaluation of the immunocompetence of pa

Evaluation of the immunocompetence of patients with transitional cell carcinoma of the bladder

✍ Adolphs, H.-D. ;Steffens, L. 📂 Article 📅 1977 🏛 Springer 🌐 English ⚖ 411 KB

The cellular immunocompetence was examined by means of the quantitative DNCB hypersensitivity reaction in 152 patients with transitional cell carcinomas of the bladder of Broders grades 1-4. Against a control group of 367 normal controls of both sexes, 85 patients with transitional cell carcinomas o

Adjuvant Bestatin immunotherapy in patie

Adjuvant Bestatin immunotherapy in patients with transitional cell carcinoma of the bladder

✍ Henric Blomgren; Ingemar Näslund; Pier-Luigi Esposti; Lise Johansen; Ove Aaskove 📂 Article 📅 1987 🏛 Springer-Verlag 🌐 English ⚖ 554 KB

The first clinical results of an ongoing, prospective trial to determine the value of adjuvant Bestatin immunotherapy in the management of bladder cancer are presented. Patients with nonmetastatic transitional cell carcinoma of the bladder, scheduled for full dose local radiation therapy (64 Gy), we